当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析

恩华药业

(002262)

  

流通市值:223.63亿  总市值:256.99亿
流通股本:8.84亿   总股本:10.16亿

恩华药业(002262)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润7.00亿元,每股收益0.69元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益764502.14万元,未分配利润596453.21万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产878852.49万元,负债114350.35万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入3,010,121,701.841,510,888,789.075,697,633,044.594,145,463,113.62
营业总成本2,233,759,335.621,172,507,853.524,403,872,157.262,995,908,599.95
其他经营收益
营业利润792,856,298.15338,602,094.11,336,573,612.011,171,393,445.37
利润总额788,404,080.87336,331,153.341,296,688,433.421,152,398,257.88
净利润700,054,285.99300,639,634.411,140,792,302.841,016,537,195.81
每股收益
其他综合收益---5,881,155.37-
综合收益总额700,054,285.99300,639,634.411,134,911,147.471,016,537,195.81
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计6,369,176,126.176,498,493,657.676,059,552,060.445,927,584,141.43
非流动资产:
非流动资产合计2,419,348,793.382,370,529,739.22,380,453,595.512,201,324,616.7
资产总计8,788,524,919.558,869,023,396.878,440,005,655.958,128,908,758.13
流动负债:
流动负债合计1,052,735,115.171,181,506,476.631,066,240,631.43929,286,535.48
非流动负债:
非流动负债合计90,768,427.7394,770,033.05100,249,246.7495,405,550.9
负债合计1,143,503,542.91,276,276,509.681,166,489,878.171,024,692,086.38
所有者权益(或股东权益):
归属于母公司股东权益合计7,672,267,779.437,619,618,940.417,300,321,724.487,131,820,421.11
股东权益合计7,645,021,376.657,592,746,887.197,273,515,777.787,104,216,671.75
负债和股东权益合计8,788,524,919.558,869,023,396.878,440,005,655.958,128,908,758.13
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计3,180,488,495.511,551,415,504.056,014,764,208.714,548,674,103.67
经营活动现金流出小计2,685,665,296.191,232,143,204.585,098,637,705.653,637,481,410.11
经营活动产生的现金流量净额494,823,199.32319,272,299.47916,126,503.06911,192,693.56
投资活动产生的现金流量:
投资活动现金流入小计4,416,678,965.762,295,107,170.326,247,928,722.264,724,980,443.94
投资活动现金流出小计4,116,883,442.531,888,916,622.997,659,406,347.445,931,626,120.6
投资活动产生的现金流量净额299,795,523.23406,190,547.33-1,411,477,625.18-1,206,645,676.66
筹资活动产生的现金流量:
筹资活动现金流入小计40,000,000-163,855,937163,533,385.37
筹资活动现金流出小计397,433,644.0812,398,245.97464,826,449.85429,231,294.36
筹资活动产生的现金流量净额-357,433,644.08-12,398,245.97-300,970,512.85-265,697,908.99
汇率变动对现金及现金等价物的影响524,324.56-136,359.25171,089.65213,136.17
现金及现金等价物净增加额437,709,403.03712,928,241.58-796,150,545.32-560,937,755.92
期末现金及现金等价物余额1,651,171,6831,926,390,521.551,213,462,279.971,448,675,069.37
补充资料:
现金及现金等价物的净增加额437,709,403.03--796,150,545.32-
最新报告期:2025-08-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳1.311.501.722025-08-01
太平洋张懿,谭紫媚1.271.451.662025-08-01
开源证券刘艺,余汝意1.271.471.722025-07-31
东吴证券朱国广1.301.501.732025-07-31
野村东方国际证券孔令岩1.301.501.722025-07-30
TOP↑